- 全部删除
您的购物车当前为空
CDK5 inhibitor 20-223(CP668863)是一种高效的CDK2/CDK5抑制剂,IC50值分别为6.0 nm和8.8 nM,具有抗结直肠癌(CRC)的潜力,在多种CRC细胞系中抑制细胞迁移和诱导细胞周期阻滞。


为众多的药物研发团队赋能,
让新药发现更简单!
CDK5 inhibitor 20-223(CP668863)是一种高效的CDK2/CDK5抑制剂,IC50值分别为6.0 nm和8.8 nM,具有抗结直肠癌(CRC)的潜力,在多种CRC细胞系中抑制细胞迁移和诱导细胞周期阻滞。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 987 | In stock | |
| 5 mg | ¥ 1,740 | 5日内发货 | |
| 25 mg | ¥ 5,970 | 6-8周 | |
| 50 mg | ¥ 7,920 | 6-8周 | |
| 100 mg | ¥ 12,200 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,830 | 5日内发货 |
CDK5 inhibitor 20-223 相关产品
| 产品描述 | CDK5 inhibitor 20-223 (CP668863) is a potent CDK2/CDK5 inhibitor with IC50 values of 6.0 nm and 8.8 nM, respectively, with anti-Colorectal Cancer (CRC) potential, inhibiting cell migration and inducing cell cycle arrest in multiple CRC cell lines. |
| 靶点活性 | CDK2/CDK5:362 nM |
| 体外活性 | CDK5 inhibitor 20-223 在结直肠癌细胞中抑制 CDK2/CDK5 活性(IC₅₀ ≈ 362 nM),诱导细胞周期阻滞,降低 RB 和 FAK 磷酸化,抑制细胞迁移[1]。 |
| 体内活性 | 在小鼠肿瘤模型中,CDK5 inhibitor 20-223(8 mg/kg,3周)显著抑制肿瘤生长,无明显毒性,降低肿瘤中 pFAK 水平[1]。 |
| 别名 | CP668863, CP 668863 |
| 分子量 | 305.37 |
| 分子式 | C19H19N3O |
| CAS No. | 865317-30-2 |
| Smiles | O=C(NC1=NNC(=C1)C2CCC2)CC=3C=CC=4C=CC=CC4C3 |
| 存储 | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (261.98 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容